IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 191 filers reported holding IMMUNOVANT INC in Q3 2023. The put-call ratio across all filers is 2.28 and the average weighting 0.6%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $13,009,717 | +27.7% | 338,883 | -36.9% | 0.00% | 0.0% |
Q2 2023 | $10,187,953 | +189.3% | 537,056 | +136.5% | 0.00% | – |
Q1 2023 | $3,522,182 | +16.6% | 227,091 | +33.4% | 0.00% | – |
Q4 2022 | $3,021,939 | +485.6% | 170,250 | +84.2% | 0.00% | – |
Q3 2022 | $516,000 | -17.0% | 92,431 | -42.1% | 0.00% | – |
Q2 2022 | $622,000 | -50.5% | 159,671 | -30.0% | 0.00% | – |
Q1 2022 | $1,256,000 | -70.3% | 228,022 | -54.1% | 0.00% | -100.0% |
Q4 2021 | $4,234,000 | -43.7% | 496,910 | -42.6% | 0.00% | 0.0% |
Q3 2021 | $7,519,000 | -53.9% | 865,246 | -43.9% | 0.00% | -50.0% |
Q2 2021 | $16,303,000 | +35.0% | 1,542,372 | +104.9% | 0.00% | 0.0% |
Q1 2021 | $12,072,000 | +240.4% | 752,651 | +880.4% | 0.00% | +100.0% |
Q4 2020 | $3,546,000 | +1766.3% | 76,769 | +1328.5% | 0.00% | – |
Q3 2020 | $190,000 | +12.4% | 5,374 | -22.6% | 0.00% | – |
Q2 2020 | $169,000 | -46.2% | 6,943 | -65.6% | 0.00% | – |
Q1 2020 | $314,000 | +1862.5% | 20,176 | +1917.6% | 0.00% | – |
Q4 2019 | $16,000 | – | 1,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RTW INVESTMENTS, LP | 7,510,412 | $264,291,000 | 6.36% |
Ghost Tree Capital, LLC | 525,000 | $18,475,000 | 5.34% |
Pinz Capital Management, LP | 199,100 | $7,006,000 | 2.56% |
ACUTA CAPITAL PARTNERS, LLC | 250,000 | $8,798,000 | 2.39% |
BVF INC/IL | 1,198,427 | $42,173,000 | 2.30% |
Cormorant Asset Management, LP | 1,637,951 | $57,639,000 | 2.22% |
Vivo Capital, LLC | 1,042,460 | $36,684,000 | 2.12% |
Parkman Healthcare Partners LLC | 150,151 | $5,284,000 | 1.40% |
MANGROVE PARTNERS IM, LLC | 230,307 | $8,105,000 | 1.02% |
Ikarian Capital, LLC | 321,887 | $11,328,000 | 0.82% |